An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Ariel Fernández, … , Anil K. Sood, Gabriel Lopez-Berestein
Ariel Fernández, … , Anil K. Sood, Gabriel Lopez-Berestein
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(11):4980-4980. https://doi.org/10.1172/JCI73378.
View: Text | PDF | Amended Article
Corrigendum

An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic

Abstract

Authors

Ariel Fernández, Angela Sanguino, Zhenghong Peng, Eylem Ozturk, Jianping Chen, Alejandro Crespo, Sarah Wulf, Aleksander Shavrin, Chaoping Qin, Jianpeng Ma, Jonathan Trent, Yvonne Lin, Hee-Dong Han, Lingegowda S. Mangala, James A. Bankson, Juri Gelovani, Allen Samarel, William Bornmann, Anil K. Sood, Gabriel Lopez-Berestein

×

Full Text PDF | Download (120.32 KB)